UNSPSC 51342903: Inosine pranobex

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51342903

Definition

This classification denotes an immunostimulant with the molecular formula C10H12N4O5.3C9H9NO3.3C5H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W1SO0V223F, chemically known as p-acetamidobenzoic salt of n,n-dimethylamino-2-propanol & inosine (3:1) np 113 but generally known as inosine pranobex, which bears US NIH Compound Identifier 37510. European Medicines Agency schedules Inosine pranobex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14214MIG.

Read the full definition

World Health Organization schedules inosine pranobex in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule inosine pranobex under HS 29349990 and SITC 51579. As of Q4 2014, INOSINE PRANOBEX remains the US FDA Preferred Term for this commodity. Inosine pranobex bears US NLM identifiers UMLS ID C0022230 and NCI Concept Code C601. SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-].CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC(=O)C2=C(N1)N(C=N2)C3C(C(C(O3)CO)O)O.

About UNSPSC 51342903

UNSPSC 51342903 Inosine pranobex is a Commodity code that describes pharmaceutical products, but recent state and local procurement activity under this code shows little alignment with the specific active ingredient named. Instead, jurisdictions are sourcing a broader range of pharmaceutical supplies and medical devices — including antibiotic tablets, naloxone (opioid antagonist), and drug deactivation systems — through consolidated purchasing vehicles and competitive bidding. The issuing bodies include state health departments and county community health programs seeking to stock emergency response and public health inventories.

Activity appears concentrated in the South and Midwest. Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse cooperative purchasing consortium, with a total value of $2,999,999.11 over the contract term including renewal options; Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the county community health building, response deadline July 26, 2023. The mismatch between the code's nominal scope (inosine pranobex, an antiviral and immunostimulant) and the pharmaceutical products actually being procured suggests this code may be applied inconsistently or as a default placeholder in state and local systems rather than for the specific active ingredient.

Quick answers

What is UNSPSC 51342903?

UNSPSC 51342903 is Inosine pranobex, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51342903?

UNSPSC 51342903 maps to 1 NIGP code, 26908 Anti-Infective Agents.

On GovTribe

See everything under UNSPSC 51342903

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code